Celsion Corporation Announces Company Name Change to Imunon, Inc.

Provided By Globe Newswire

Last update: Sep 19, 2022

New name reflects the evolution of the Company’s business focus and its commitment to immunotherapies and vaccines

LAWRENCEVILLE, N.J., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage drug development company, today announced a company name change to Imunon, Inc., reflecting the evolution of the Company’s business focus and its commitment to developing cutting-edge immunotherapies and next-generation vaccines to treat cancer and infectious diseases.